Cellera Farma
  • Cellera
  • Partnering
  • Products
    • Vitamins and Supplements
    • Prescription Medications
    • Over-the-Counter Medicines
  • Careers
  • My Health
  • Contact
  • pt_BR
  • Search
  • Menu Menu
  • Contact

    We have several channels of
    assistance available to listen to you.
    Feel free to talk to us!

    banner contato
imagem contato por e-mail

For e-mail contact, send your questions, suggestions, or complaints to the address below, providing your name and necessary details.

sac@cellerafarma.com.br

imagem contato ao telefone

If you prefer, contact us directly at the phone number below to discuss questions, suggestions, or complaints:

0800 58 000 32

Send a message:

Please fill in the fields below so that we can contact you as soon as possible.

    Pharmacovigilance

    In which cases should you contact Pharmacovigilance?

    According to Anvisa's RDC 406/2020, Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse events or any other problems related to medicines. The responsibility for ensuring the safety of medication use lies with everyone: pharmaceutical industries, regulatory agencies, healthcare professionals, and also patients.

    An adverse event is any undesirable medical occurrence in a patient administered a medication, without necessarily having a causal relationship with the treatment, it can be any unfavorable and unintended sign, symptom, or temporally associated disease related to the use of the medication.

    Therefore, upon becoming aware of an adverse event related to the use of a medication from Cellera Farma or its partners, we advise you to contact Customer Service Center (SAC) at 0800 58 000 32, Monday to Friday (except holidays), from 8:30 AM to 4:00 PM, or by email at sac@cellerafarma.com.br.

    Important notice: We do not provide any medical advice regarding health issues, which should be addressed by your trusted physician.

    Therefore, it is considered as an adverse event:

    • ABUSE OF MEDICINES

      Intentional excessive use of one or more medicines without a therapeutic purpose and without a prescription, which can be persistent or sporadic, accompanied by harmful physical or psychological effects.

    • EXPOSURE TO MEDICINE DURING PREGNANCY AND LACTATION

      It is the exposure of the fetus/baby/child to a drug via the father (during conception) or mother (during conception, pregnancy, childbirth or breastfeeding) Cases of exposure via the father/mother must be reported with or without a reaction.

    • ADVERSE REACTION

      Any harmful or undesirable, unintentional response to a medicine, occurring in the doses usually used in humans for prophylaxis, diagnosis, therapy of disease or for the modification of physiological functions. Unlike the Adverse Event, the Adverse Reaction is characterized by the suspicion of a causal relationship between the medicine and the harmful or undesirable response. For reporting purposes, if an event is reported spontaneously, even if the relationship is unknown or undeclared, it meets the definition of an adverse reaction.

    • ADVERSE EVENTS DUE TO QUALITY DEVIATION

      Any unfavorable medical event that may occur during treatment with a medicine, associated with a technical complaint involving the same medicine (e.g. changes in color, odor, taste, consistency).

    • THERAPEUTIC INEFFECTIVENESS

      Absence or reduction of the expected therapeutic response of the medicine, under the conditions of use indicated in the package leaflet.

    • OVERDOSE

      Use of medicine in doses higher than the maximum recommended dose, i.e. in excess of the recommended dose.

    • MEDICATION ERROR

      Any preventable event that may cause or lead to the inappropriate use of medicines, or cause harm to a patient, while the medication is under the control of healthcare professionals, patients or consumers, involving unintentional use, with a therapeutic purpose, and may or may not have a prescription. This event can be related to professional practice, health products, procedures and systems, including prescription, verbal guidance, labeling, packaging and nomenclature of industrialized and manipulated products, dispensing, distribution, administration, education, monitoring and use.

    • DRUG INTERACTION

      Pharmacological, toxicological, clinical or laboratory response caused by the combination of the medicine with other medicines. It can also result from the medicine's interaction with food, chemical substances or diseases. The reliability of laboratory test results can be affected by drug interactions. Drug interaction can result in an increase or decrease in therapeutic effectiveness or the appearance of new related adverse events.

    • OFF LABEL USE

      This includes intentional use in situations that differ from the leaflet of a medicine registered with Anvisa, for therapeutic purposes and on prescription. This can include differences in indication, age/weight range, dose, frequency, presentation or route of administration.

    Ethics and compliance

    This communication channel is aimed at reporting situations of non-compliance with Cellera Farma's policies and standards, which can be done confidentially or anonymously. Click here to download our code of conduct.

    All incidents reported will be forwarded for verification by Cellera Farma's Ethics and Compliance Area. All information reported here will be treated confidentially, and its veracity and actions taken are the responsibility of the reporter and Cellera Farma.

    Ethics Channel

    Do not remain silent; report any and all non-compliance with regulations.

    (11) 4580-0569
    http://missaocompliance.com.br/canal-etico/cellera/
    E-mail: canal-etico-cellera@missaocompliance.com.br

    What should not be registered?

    Themes exclusively related to product quality and pharmacovigilance should not be forwarded through the Ethics Channel, but through the Customer Service Channel.

    What is the Ethics Channel?

    It is an independent channel available for reporting any suspicion of non-compliance with internal regulations or laws.

    When should I make a report?

    Whenever any irregularities involving our employees are identified, even if they are just suspicions.

    Who can make a report?

    The channel can be used by employees, third parties, clients, suppliers, as well as anyone who may wish to make a report, using the channels indicated above.

    Do I need to identify myself?

    No. You can make an anonymous report. The channel is managed by a third-party company, so anonymity can be guaranteed. We do not tolerate any kind of retaliation against the reporter, observing the principles of ethics and good faith.

    What happens to my report?

    All reports are analyzed impartially and independently. If the allegations are true, disciplinary measures could be applied.

    Form Ethics and Compliance:

    In the form below you must describe the situation of non-compliance with Cellera Farma's Code of Ethics.

      cellera farma logo

      Follow us on social media

      © Copyright - Cellera Farma Privacy Policy
      Scroll to top

      Nós usamos cookies e outras tecnologias semelhantes para melhorar sua experiência em nossos serviços, personalizar publicidade e recomendar conteúdo de seu interesse.
      Ao utilizar nossos serviços você concorda com tal monitoramento.
      Confira nossa Privacy Policy.

      ProsseguirNegar

      Cookie and Privacy Settings



      How we use cookies

      We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

      Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

      Essential Website Cookies

      These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

      Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

      We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

      We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

      Other external services

      We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

      Google Webfont Settings:

      Google Map Settings:

      Google reCaptcha Settings:

      Vimeo and Youtube video embeds:

      Privacy Policy

      You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

      Política de privacidade

      Accept settingsHide notification only

      Pay Equity Report

      DOWNLOAD PDF

      Diversity and Inclusion Handbook

      DOWNLOAD PDF

      Disposal of Medication

      DOWNLOAD PDF

      “A Cellera iniciou suas atividades em maio 2017, a partir da aquisição da Delta Farmacêutica e parte dos ativos da Valeant (hoje Bausch & Lomb), com o investimento do Principia Capital Partners em parceria com Omilton Visconde Jr, um expoente empresário do mercado farmacêutico brasileiro.

      Since then, Cellera has built its path based on a unique and innovative business model, with a strategic focus on promoting and distributing established brands in the market. This operational model has provided us with accelerated growth and expanded our presence in the sector through major partnerships and acquisitions.

      Thus, in the second year of operations, we acquired Pamelor (Novartis) and Benerva (Bayer), in addition to announcing, in the same year, the licensing of the world’s best-selling probiotic: Culturelle from I-health, a company of the DSM group. At that point, we materialized our entry into the prescription drug market.

      The following year, we finalized a promotion and distribution agreement with Janssen Pharmaceuticals, which further strengthened our operation and allowed Cellera to double its size. Subsequently, new opportunities arose with the purchase of Tylex (Janssen), as well as new promotion and distribution agreements with Sanofi, Ferring, and Servier.

      In fact, the Brazilian pharmaceutical market has some peculiarities. Large pharmaceutical companies generally focus their investments on innovation, directing resources towards the development of high-cost molecules, consequently reducing the promotion of important and prominent products.

      Cellera identified an opportunity to take advantage of the 'long tail' of some medications, aiming to maximize the lifespan of these drugs, which often end up suffering a reduction in their promotion. In general, they are still very interesting products, with good revenue and significant sales opportunities. Some pharmaceutical companies, aligned with their investment strategies, prefer to seek partnerships to carry out the promotion and distribution of these drugs rather than discontinuing them. Our goal is precisely to ensure that these brands continue to gain market share."

      Login

      Acesso restrito a profissionais de saúde. Faça seu login ou cadastre-se para ter acesso a conteúdos exclusivos.

      [wpmem_form login]